Dr. Othman Cole
LinkedIn Copy
Hi Othman — Zimbabwean by background, did M&A banking then growth equity at a European fund. Now running UK SME origination. Built a list of 322 UK companies open to sale — two looked relevant for VFC so happy to share.
Email Copy
Subject B: Two names for VFC
Hi Othman, Given you back uk healthcare and manufacturing companies, you're likely frustrated with good dealflow. So, I thought I'd extend a small favor and share two names from my proprietary outreach that might be a fit. One is: Croyde Medical, a £5-10m specialist manufacturer of critical care and thermal management medical equipment serving public and private healthcare providers. And another is: A £5-10m independent pharmaceutical business developing and manufacturing prescription medicines for specialist therapeutic areas in the UK market. The two names are part of a full 322 long list of targets that are open to sale. Targets derived from conversations with over 500 owners over the past 9 months. Here's a link to the full anonymised list: sample.searchloop.ai At searchloop, I build custom software to generate proprietary conversations with business owners. We've had success with 20+ funds, some with >£500m in AUM some with £10m. Happy to walk you through how it works. Send me a reply and we can schedule a quick 20 min call. very best, Russ linkedin.com/in/russellt23 PS: if this isn't relevant, reply no and I'll leave you in peace. might even go for a walk.
Hi Othman — quick second note in case the first got buried. a bit more detail: I've built proprietary origination tools for 20+ funds, each covering a differentiated, human-in-the-loop approach. The 322-company list is one output of the pipeline. Another is a research piece I wrote that maps several UK services sub-sectors by opportunity and level of market interest. This is based on investor signal that we've received via our engagements. Here's the link: sample.searchloop.ai/research/uk-services (drone inspection, data center electrical maintenance, site prep & tic emerge are some of the featured sectors) Just reply to this email if you'd like to chat through it or the proprietary list. very best, Russ linkedin.com/in/russellt23 PS: if this isn't relevant, reply no and I'll leave you in peace. might even go for a walk.
Othman, Another fit from our 322 company list for VFC: Action For Care, a £10-25m provider of residential facilities offering specialist care for individuals with complex neurological and high-acuity behavioural needs. sound interesting? PS: if this isn't relevant, reply no and I'll leave you in peace. might even go for a walk.
Hi Othman going to assume the timing's off, I'll leave it there. The list and research are there when you want them. Very best, Russell. PS: if this isn't relevant, reply no and I'll leave you in peace. might even go for a walk.
Response
Status
Interested
Channel
Interest
Interested
Sentiment
The prospect acknowledged the message and committed to reviewing the offer, indicating positive engagement.
Thanks Russell. We'll review and get back to you as soon as possible. Kind regards
Thanks Russell. We'll review and get back to you as soon as possible. Kind regards On Fri, May 8, 2026 at 3:07 PM Russell Taylor wrote: > Hi Alex - short deck attached. > > can discuss exactly what solution 2 lane vs. multi fits VF on the call. > > I am around most afternoons next week: > > Monday & Wednesday 2pm BST onwards > Tuesday 3pm BST onwards > Thur 4pm BST onwards > > let me know when suits best, > R. > > On Thu, May 7, 2026 12:22:17 PM Alex Dumitru alex.dumitru@dominion-corp.com> wrote: > > Thank you for clarifying Russell. > > We are actively looking to purchase businesses. > > Can you send us a presentation containing a pricing structure that we can > review before our call? > > Thank you. > > Kind regards, > > On Wed, May 6, 2026 at 11:22 PM Russell Taylor > wrote: > >> Hi Alex, >> >> Thanks for the quick reply — glad those caught your eye. >> >> Just to clarify how we work: SearchLoop is a consulting business. We >> build bespoke deal origination systems for funds — so the pipeline, >> enrichment, and outreach infrastructure that surfaces opportunities like >> these on an ongoing basis. >> >> The two businesses I referenced were examples of what our system >> identified through direct outreach to UK business owners. We're not >> representing those companies or running a brokered process, so >> unfortunately I'm not in a position to share financials or facilitate >> introductions under NDA. >> >> What I can do is build the same kind of origination capability in-house >> for VF Capital — so you'd have a steady flow of proprietary, off-market >> conversations with owners in your target sectors. >> >> Happy to jump on a call with you and Othman if that's of interest. >> >> Best, >> Russ >> On Wed, May 6, 2026 2:32:01 PM Alex Dumitru > alex.dumitru@dominion-corp.com> wrote: >> >> Hi Russell >> I hope you are well. >> Thank you for reaching out and for sharing these opportunities. They are >> indeed of interest, particularly the specialist manufacturer of critical >> care and thermal management medical equipment. >> I am working with Dr. Othman Cole and the team at VF Capital, and we >> would be keen to learn more about both businesses. Would you be able to >> share further information under an NDA? Please feel free to forward your >> standard NDA, or we can provide ours if preferred. >> In the meantime, it would be helpful to understand indicative valuation >> expectations and a high-level overview of current financial performance. >> I would also be happy to arrange a brief call to discuss these >> opportunities further. >> I look forward to hearing from you. >> Kind regards, >> >> >> This message (which includes any attachments) is intended only for the >> designated recipient(s). It may contain confidential or proprietary >> information of Dominion Corporate Solutions SRL and may be subject to the >> attorney-client privilege or other confidentiality protections. If you are >> not a designated recipient, you may not review, use, copy or distribute >> this message. If you received this in error, please notify the sender by >> reply e-mail and delete this message. Thank you. >> >> On Wed, 6 May 2026 at 00:22, Othman Cole >> wrote: >> >>> >>> >>> >>> ------------------------------ >>> *From:* Russell Taylor >>> *Sent:* Tuesday, May 5, 2026 2:44 pm >>> *To:* Dr. Othman Cole >>> *Subject:* Two ideas for VFC >>> >>> Othman — >>> >>> Given you're backing healthcare companies, I figured we probably share >>> some overlap. Though, I'm from Zimbabwe, and did direct SME investments for >>> a European fund. >>> >>> Now I build origination systems for funds like yours and over the past 6 >>> months, we've had 300+ direct conversations with UK business owners. Of all >>> those targets, the two that felt closest to what you're looking for are: >>> >>> • A £5-10m revenue specialist manufacturer of critical care and thermal >>> management medical equipment serving public and private healthcare >>> providers. >>> • A £5-10m revenue independent pharmaceutical business developing and >>> manufacturing prescription medicines for specialist therapeutic areas in >>> the UK market. >>> >>> Here's a link to the full anonymised list: sample.searchloop.ai >>> >>> Let me know if you'd like to chat about how these were surfaced. >>> >>> very best, >>> Russ >>> >>> linkedin.com/in/russellt23 >>> >> > > -- > > This message (which includes any attachments) is intended only for the > designated recipient(s). It may contain confidential or proprietary > information of Dominion Corporate Solutions SRL and may be subject to the > attorney-client privilege or other confidentiality protections. If you are > not a designated recipient, you may not review, use, copy or distribute > this message. If you received this in error, please notify the sender by > reply e-mail and delete this message. Thank you. > > -- This message (which includes any attachments) is intended only for the designated recipient(s). It may contain confidential or proprietary information of Dominion Corporate Solutions SRL and may be subject to the attorney-client privilege or other confidentiality protections. If you are not a designated recipient, you may not review, use, copy or distribute this message. If you received this in error, please notify the sender by reply e-mail and delete this message. Thank you.